This activity is expired and is no longer available for CME credit.


No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study

Author(s)/Faculty: Patricia K. Coyle, MD, FAAN
Release Date: 12/15/2014Expiration Date: 11/12/2016
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider: Vindico Medical Education
Dr. Coyle discusses the most current research on the effect of interferon β-1a SC vs. interferon β-1a IM in patients with MS.